O’Shaughnessy, J. (2020). Treatment options for patients with HR+/HER2− advanced breast cancer during the COVID-19 pandemic: Dose reduction of ribociclib does not diminish efficacy. Breast Cancer Res Treat.
Stile di citazione ChicagoO’Shaughnessy, Joyce. "Treatment Options for Patients With HR+/HER2− Advanced Breast Cancer During the COVID-19 Pandemic: Dose Reduction of Ribociclib Does Not Diminish Efficacy." Breast Cancer Res Treat 2020.
Citazione MLAO’Shaughnessy, Joyce. "Treatment Options for Patients With HR+/HER2− Advanced Breast Cancer During the COVID-19 Pandemic: Dose Reduction of Ribociclib Does Not Diminish Efficacy." Breast Cancer Res Treat 2020.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.